Daiwa Securities Group
FHTX icon

Daiwa Securities Group’s Foghorn Therapeutics FHTX Stock Holding History

Daiwa Securities Group’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-168
Closed -$1K – 1345
2023
Q3 		$1K Hold
168
– – ﹤0.01% 1251
2023
Q2 		$1K Hold
168
– – ﹤0.01% 1273
2023
Q1 		$1K Hold
168
– – ﹤0.01% 1251
2022
Q4 		$1K Buy
+168
New +$1.27K ﹤0.01% 1267

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Daiwa Securities Group's FHTX Position: Q4 2023 in Review

Daiwa Securities Group sold out of Foghorn Therapeutics (FHTX) in Q4 2023, closing a stake of 168 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in FHTX in Q4 2022 and held it in 4 quarters. The position peaked at $1K in Q3 2023. 59 funds tracked by Wall St. Rank hold FHTX as of Q4 2023.

  • Daiwa Securities Group reported no remaining Foghorn Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 168 Foghorn Therapeutics shares in Q4 2023, an estimated $1K.
  • Daiwa Securities Group first reported a position in Foghorn Therapeutics in Q4 2022 and held it in 4 quarters.
  • Daiwa Securities Group's Foghorn Therapeutics position peaked at $1K in Q3 2023.
  • 59 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.